164 related articles for article (PubMed ID: 36389832)
1. COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation.
Shi W; Chen Z; Liu H; Miao C; Feng R; Wang G; Chen G; Chen Z; Fan P; Pang W; Li C
Front Immunol; 2022; 13():937125. PubMed ID: 36389832
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis.
Zheng H; Tan J; Qin F; Zheng Y; Yang X; Qin X; Liao H
BMC Med Genomics; 2024 Apr; 17(1):97. PubMed ID: 38649961
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
5. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
Front Immunol; 2022; 13():998140. PubMed ID: 36275774
[TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
Zhu K; Cai L; Cui C; de Los Toyos JR; Anastassiou D
PLoS Comput Biol; 2021 Jul; 17(7):e1009228. PubMed ID: 34283835
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
8. Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination.
Truong DQ; Ho BT; Chau GC; Truong DK; Pham TTT; Nakagawara A; Bui CB
Pediatr Dev Pathol; 2022; 25(2):91-98. PubMed ID: 34460335
[TBL] [Abstract][Full Text] [Related]
9. Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures.
Li J; Qiu J; Han J; Li X; Jiang Y
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360212
[TBL] [Abstract][Full Text] [Related]
10. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer.
Luo Q; Li J; Su X; Tan Q; Zhou F; Xie S
Front Genet; 2022; 13():935860. PubMed ID: 36160004
[TBL] [Abstract][Full Text] [Related]
11. Weighted Gene Coexpression Network Analysis Identifies TBC1D10C as a New Prognostic Biomarker for Breast Cancer.
Qiao H; Lv R; Pang Y; Yao Z; Zhou X; Zhu W; Zhou W
Anal Cell Pathol (Amst); 2022; 2022():5259187. PubMed ID: 35425695
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
13. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients.
Geng S; Fu Y; Fu S; Wu K
Front Immunol; 2022; 13():927565. PubMed ID: 36059555
[TBL] [Abstract][Full Text] [Related]
14. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
[TBL] [Abstract][Full Text] [Related]
15. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y
Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
19. Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens.
Karaglani M; Toumpoulis I; Goutas N; Poumpouridou N; Vlachodimitropoulos D; Vasilaros S; Rizos I; Kroupis C
BMC Cancer; 2015 Oct; 15():694. PubMed ID: 26466668
[TBL] [Abstract][Full Text] [Related]
20. Collagen, type XI, alpha 1: an accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies.
Freire J; Domínguez-Hormaetxe S; Pereda S; De Juan A; Vega A; Simón L; Gómez-Román J
Pathol Res Pract; 2014 Dec; 210(12):879-84. PubMed ID: 25175819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
